INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candida | INO Message Board Posts


Inovio Biomedical Corporation

  INO website

INO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  2133 of 2142  at  8/28/2021 10:17:26 AM  by

co3aii


 In response to msg 2132 by  billmax
view thread

Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800

We looked at homes on Lake Wallenpaupack years ago and while they were old they were very nice but we decided we preferred the ocean and Cape Cod.
 
I sold most of my INO in the $20s as the run  up was too frenzied for me to hold. I am buying currently and building a position. 
 
INO was one of the companies in my Glioblastoma Multiforme mini portfolio, its one of two I owned still involved with brain cancer. Peregrine sold its drug (mab) business and became Avid(CDMO) and has done very well. If INO does anything with Glio it  will dwarf vaccine revenues as while Covd vaccines are now very competitive, no one has anything effective for Glio. 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 1  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
2134 Re: INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800 billmax 0 8/28/2021 11:06:04 AM


Financial Market Data provided by
.
Loading...